Rhoshel Lenroot Selected Research

Proteins (Proteins, Gene)

1/2024	Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial.
1/2022	Peripheral complement is increased in schizophrenia and inversely related to cortical thickness.
9/2017	Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rhoshel Lenroot Research Topics

Disease

16	Schizophrenia (Dementia Praecox) 01/2024 - 03/2003
7	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 03/2003
5	Inflammation (Inflammations) 01/2024 - 09/2017
2	Chronic Disease (Chronic Diseases) 01/2024 - 01/2018
2	Cerebral Cortical Thinning 12/2023 - 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2016
1	Learning Disabilities (Learning Disability) 09/2015
1	Autistic Disorder (Autism) 01/2012
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 07/2006
1	Digitorenocerebral Syndrome 03/2003

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 01/2024 - 09/2017
4	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 03/2003
3	C-Reactive ProteinIBA 01/2024 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2017
3	CytokinesIBA 01/2022 - 09/2017
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 02/2005
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2020 - 02/2005
3	Testosterone (Sustanon)FDA Link 06/2015 - 07/2006
2	Complement System Proteins (Complement)IBA 12/2023 - 01/2022
2	Protons (Proton)IBA 01/2021 - 10/2020
2	CreatineIBA 01/2021 - 10/2020
2	Glutamine (L-Glutamine)FDA Link 01/2021 - 10/2020
2	Raloxifene Hydrochloride (Evista)FDA Link 12/2016 - 09/2015
2	Selective Estrogen Receptor Modulators (SERM)IBA 12/2016 - 09/2015
2	Estrogen ReceptorsIBA 12/2016 - 09/2015
1	InterleukinsIBA 01/2024
1	Saline SolutionIBA 01/2024
1	canakinumab FDA Link 01/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Dehydroepiandrosterone (DHEA)IBA 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	Inositol (Myoinositol)IBA 01/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2021
1	N-Methylaspartate (NMDA)IBA 01/2021
1	Kynurenic Acid (Kynurenate)IBA 11/2020
1	Transaminases (Aminotransferases)IBA 11/2020
1	EnzymesIBA 11/2020
1	KynurenineIBA 11/2020
1	Tryptophan (L-Tryptophan)FDA Link 11/2020
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 09/2017
1	Interleukin-2 (IL2)IBA 09/2017
1	Interleukin-8 (Interleukin 8)IBA 09/2017
1	Interleukin-10 (Interleukin 10)IBA 09/2017
1	Estrogen Receptor alphaIBA 12/2016
1	DNA (Deoxyribonucleic Acid)IBA 10/2016
1	Hormones (Hormone)IBA 01/2013
1	SteroidsIBA 01/2013
1	Clozapine (Clozaril)FDA LinkGeneric 03/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2016 - 03/2003
1	Subcutaneous Injections 01/2024
1	Transcranial Direct Current Stimulation 01/2012
1	Therapeutics 03/2003
1	Deinstitutionalization 03/2003
1	Secondary Prevention 03/2003